Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 25Prostatic Neoplasms 23Carcinoma, Non-Small-Cell Lung 15Multiple Myeloma 14Sarcoma 12Leukemia, Myeloid, Acute 12Breast Neoplasms 12Lymphoma, Non-Hodgkin 10Glioma 10Wilms Tumor 9Colorectal Neoplasms 9Carcinoma, Hepatocellular 9Rectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Pancreatic Neoplasms 8Ovarian Neoplasms 8Osteosarcoma 8Neuroblastoma 8Neoplasm Metastasis 8Myelodysplastic Syndromes 8Rhabdomyosarcoma 7Rhabdoid Tumor 7Melanoma 7Medulloblastoma 7Hepatoblastoma 7Neuroectodermal Tumors, Primitive, Peripheral 6Mouth Neoplasms 6Lymphoma 6Histiocytosis, Langerhans-Cell 6Head and Neck Neoplasms 6

Interventions

Magnetic Resonance Spectroscopy 4olaparib 1gallium 68 PSMA-11 1durvalumab 1X-Rays 1Specimen Handling 1Radiation 1Photons 1Lutetium-177 1Immunoglobulin G 1Disulfides 1Congresses as Topic 168Ga-DKFZ-PSMA-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Biochemically Recurrent Prostate Carcinoma × X-Rays × Clear all
NCT06105918 2025-12-09

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Emory University

Phase 1 Active not recruiting
6 enrolled
Genitourinary

Biochemically Recurrent Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡